DARGLITAZONE SODIUM
UNII A1P35HS4XI

Substance Identification & Data

This profile provides standardized clinical and technical data for Darglitazone Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A1P35HS4XI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 141683-98-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A1P35HS4XI

CAS Registry Number

141683-98-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DARGLITAZONE SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H19N2O4S.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AMCPCELVARAPHJ-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C75188

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23707497

Unique identification number in the NCBI database of chemical substances.

USAN ID

EE-80

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[N-]1C(SC(C1=O)Cc2ccc(C(CCc3nc(-c4ccccc4)oc3C)=O)cc2)=O.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Darglitazone Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.